Tislelizumab Combined APF Chemotherapy in the Treatment of Locally Advanced Head and Neck Tumors
Clinical trial NCT05758389 · RECRUITING
Trial details
- NCT number
- NCT05758389
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-01
- Primary completion
- 2025-08-07
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.